JPS5524118A - Microcapsulated preparation for mitomycinc - Google Patents

Microcapsulated preparation for mitomycinc

Info

Publication number
JPS5524118A
JPS5524118A JP9647878A JP9647878A JPS5524118A JP S5524118 A JPS5524118 A JP S5524118A JP 9647878 A JP9647878 A JP 9647878A JP 9647878 A JP9647878 A JP 9647878A JP S5524118 A JPS5524118 A JP S5524118A
Authority
JP
Japan
Prior art keywords
preparation
mitomycin
ethyl cellulose
effect
mitomycinc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP9647878A
Other languages
Japanese (ja)
Other versions
JPS6241204B2 (en
Inventor
Tetsuo Kato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP9647878A priority Critical patent/JPS5524118A/en
Publication of JPS5524118A publication Critical patent/JPS5524118A/en
Publication of JPS6241204B2 publication Critical patent/JPS6241204B2/ja
Granted legal-status Critical Current

Links

Abstract

PURPOSE: The title preparation capable of prolonging the effect and reducing the side effects, comprising carcinostatic agent mitomycin C particles coated with ethyl cellulose.
CONSTITUTION: Mitomycin C is dispersed in a warm solution comprising ethyl cellulose, polyethylene, and cyclohexane, cooled gradually, and coated with the ethyl cellulose. A surfactant, e.g. polyoxyethylene hardened castor oil derivative, which is acceptable in the living body, to give a microcapsule preparation of mitomycin C. The preparation can be floated on the injection liquid and injected into the blood vessel. The effect is prolonged with very little flow outside the kidney.
COPYRIGHT: (C)1980,JPO&Japio
JP9647878A 1978-08-08 1978-08-08 Microcapsulated preparation for mitomycinc Granted JPS5524118A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9647878A JPS5524118A (en) 1978-08-08 1978-08-08 Microcapsulated preparation for mitomycinc

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9647878A JPS5524118A (en) 1978-08-08 1978-08-08 Microcapsulated preparation for mitomycinc

Publications (2)

Publication Number Publication Date
JPS5524118A true JPS5524118A (en) 1980-02-21
JPS6241204B2 JPS6241204B2 (en) 1987-09-02

Family

ID=14166147

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9647878A Granted JPS5524118A (en) 1978-08-08 1978-08-08 Microcapsulated preparation for mitomycinc

Country Status (1)

Country Link
JP (1) JPS5524118A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0724880A1 (en) * 1995-02-03 1996-08-07 Eurand America, Incorporated Procedure for encapsulating chlorpheniramine
JP2002511402A (en) * 1998-04-09 2002-04-16 エウランド インターナショナル ソシエタ ペル アチオニ Hygroscopic microcapsules having a core coated with a hydrophobic polymer

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0724880A1 (en) * 1995-02-03 1996-08-07 Eurand America, Incorporated Procedure for encapsulating chlorpheniramine
JP2002511402A (en) * 1998-04-09 2002-04-16 エウランド インターナショナル ソシエタ ペル アチオニ Hygroscopic microcapsules having a core coated with a hydrophobic polymer

Also Published As

Publication number Publication date
JPS6241204B2 (en) 1987-09-02

Similar Documents

Publication Publication Date Title
JPS55153715A (en) Prolonged granule of theophylline
SE8304143L (en) PERFLUOROCHEMICAL EMULSION FOR ARTIFICIAL BLOOD
JPS5795920A (en) Remedy for respiratory disease
MX9300964A (en) METHOD TO REDUCE BAD ODOR IN ABSORBENT PRODUCTS AND PRODUCTS FORMED BY THE SAME.
JPS5793910A (en) Preparation of emulsion for intravenous injection
IE891919L (en) Pharmaceutical dosage form for the medication of fish
SE8300577D0 (en) COVERAGE PROVIDING REGULATED DELIVERY OF ACTIVE INGREDIENTS FROM BIOLOGICALLY ACTIVE MIXTURES, IN PARTICULAR PHARMACEUTICAL PREPARATIONS, AS WELL AS TO MAKE BIOLOGICALLY ACTIVE MIXTURES WITH REGULATED ....
ES2090712T3 (en) ACUTE MEDICINE CONTAINING IBUPROPHEN AND ITS USE.
JPS5636411A (en) Liquid agent for external use
JPS5524118A (en) Microcapsulated preparation for mitomycinc
HU9601416D0 (en) Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide
JPS52130922A (en) Remedy for cerebral blood flow disorders containing coenzyme-q as main ingredient
JPS57142911A (en) Absorption-improving agent
JPS5244222A (en) Method of making insulin preparations for rectal application
JPS5470428A (en) Carcinostatic agent
JPS56100716A (en) Drug administration member
JPS56131514A (en) Ketoprofen composition for rectum administration
JPS5793913A (en) Enhancing agent for spermous vital power
Snyder et al. Effect of Escherichia coli Alpha-Hemolysin on Human Peripheral Leukocyte Viability In Vitro.
GR1002731B (en) Medicinal solutions containing combinations of paracetamol and other active ingredients
FR2347924A1 (en) Injectable medicaments contg. active ingredient in an emulsion - suspended in an aqueous medium
JPS5326316A (en) Drug containing active vitamin d3 derivatives and its preparation
JPS5517326A (en) Creamy drug for external use, and its preparation
JPS5519959A (en) Cooling wing
JPS5630910A (en) Glucide transfusion agent